CIS™ enters an established scientific conversation.
EvidenceWe are giving it language, structure, and support.
Clinical intuition is not new. It has been described, studied, and relied upon for decades. What remains difficult is making the cognition behind recognition visible enough to examine, communicate, and deliberately strengthen.
CIS™ is being built to address that gap.
“I just had a feeling something wasn’t right. The numbers didn’t show it yet, but I knew we needed to watch them closer.”
“She looked okay on paper, but I could tell she was getting worse. I escalated, and within an hour she decompensated.”
“We talk about gut feelings like they aren’t real. But those instincts are often the early warning system.”
“New nurses second guess themselves. We need to teach them to trust what they’re seeing and feeling.”
From bedside conversations to leadership interviews, one theme is consistent: Clinical concern can emerge before conventional measures fully explain why.
Research has examined nurses’ worry, intuition, pattern recognition, and concern as signals associated with patient deterioration.
Literature on structured communication, escalation, speaking up, and deterioration response supports the importance of translating concern into action.
Literature on reflective practice, deliberate learning, clinical reasoning, and metacognition supports structured examination of decisions and outcomes.
These sources support the scientific foundations underlying CIS™. None of them evaluate CIS™, TRM-4™, VOICE™, or CRISP™.
Clinical intuition is no longer absent from the scientific conversation. Researchers are examining how intuitive clinical concern can be defined, measured, combined with objective assessment, and incorporated into clinical systems.
That progress has also exposed important questions that remain unresolved: subjectivity, inconsistent definitions, integration with objective clinical data, external validation, and how intuitive recognition should influence action.
Uncertainty is not a weakness in the evidence. It identifies where the next questions live.
Existing research tells us that clinical concern can contain meaningful information. What remains unresolved is how best to make the cognition behind recognition sufficiently visible to teach, communicate, support, examine, and improve.
CIS™ proposes one structured answer — and now that answer needs to be tested.
CIS™ provides a structured pathway from recognition to communication, action, and reflection — creating an architecture that can be examined, taught, tested, and refined.
The next evidence will come from practice.
CIS™ is entering its evidence-building phase. We are seeking clinical, academic, and organizational partners interested in evaluating structured clinical cognition in real environments.